CANF ▲ +6.2% - Can-Fite BioPharma Ltd.
$CANF - Can-Fite Announces Eurasian Patent Allowance Supporting Piclidenoson Development and Commercialization in Lowe Syndrome
02-NOV-2026 07:00 AM ET
Share this post
More filings for $CANF
CANF ▲ +10.1% - Can-Fite BioPharma Ltd.Oct 26, 2026CANF ▲ +1.8% - Can-Fite BioPharma Ltd.Sep 9, 2026CANF ▲ +3.1% - Can-Fite BioPharma Ltd.Sep 8, 2026CANF ▼ -13.1% - Can-Fite BioPharma Ltd.Sep 2, 2026CANF ▲ +39.4% - Can-Fite BioPharma Ltd.Sep 2, 2026
View full $CANF filing history →💬 Comments
Loading comments…
Leave a comment